These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16424394)

  • 1. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action.
    Cao R; Björndahl MA; Gallego MI; Chen S; Religa P; Hansen AJ; Cao Y
    Blood; 2006 May; 107(9):3531-6. PubMed ID: 16424394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
    Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
    Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
    Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor promotes lymphatic vessel formation and function.
    Kajiya K; Hirakawa S; Ma B; Drinnenberg I; Detmar M
    EMBO J; 2005 Aug; 24(16):2885-95. PubMed ID: 16052207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study of the hepatocyte growth factor contributing to lymphangiogenesis and lymphatic metastasis in gastric cancer].
    Zhang QH; Qian K; Li XJ; Pu J; Wu XT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):212-6. PubMed ID: 17520376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
    Cao Y; Zhong W
    Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
    Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A).
    Nishida-Fukuda H; Araki R; Shudou M; Okazaki H; Tomono Y; Nakayama H; Fukuda S; Sakaue T; Shirakata Y; Sayama K; Hashimoto K; Detmar M; Higashiyama S; Hirakawa S
    J Biol Chem; 2016 May; 291(20):10490-500. PubMed ID: 26966180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
    Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK
    Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.
    Cursiefen C; Maruyama K; Jackson DG; Streilein JW; Kruse FE
    Cornea; 2006 May; 25(4):443-7. PubMed ID: 16670483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer.
    Shimizu K; Kubo H; Yamaguchi K; Kawashima K; Ueda Y; Matsuo K; Awane M; Shimahara Y; Takabayashi A; Yamaoka Y; Satoh S
    Cancer Sci; 2004 Apr; 95(4):328-33. PubMed ID: 15072591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of blood vessel versus lymphatic vessel growth in the cornea.
    Chung ES; Saban DR; Chauhan SK; Dana R
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1613-8. PubMed ID: 19029028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.
    He Y; Rajantie I; Pajusola K; Jeltsch M; Holopainen T; Yla-Herttuala S; Harding T; Jooss K; Takahashi T; Alitalo K
    Cancer Res; 2005 Jun; 65(11):4739-46. PubMed ID: 15930292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.